摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-n-Propylaminopyrimidin | 45815-12-1

中文名称
——
中文别名
——
英文名称
4-n-Propylaminopyrimidin
英文别名
propyl-pyrimidin-4-yl-amine;N-propylpyrimidin-4-amine
4-n-Propylaminopyrimidin化学式
CAS
45815-12-1
化学式
C7H11N3
mdl
——
分子量
137.184
InChiKey
VVOIYIAQBRDFQU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    257.4±13.0 °C(Predicted)
  • 密度:
    1.068±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    37.8
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • FUSED PYRIMIDINES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF)
    申请人:GLAXO GROUP LIMITED
    公开号:EP1383747A1
    公开(公告)日:2004-01-28
  • PYRIMIDINE DERIVATIVES AS 11BETA-HSD1 INHIBITORS
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1763517A2
    公开(公告)日:2007-03-21
  • Biarylurea derivatives
    申请人:Hayama Takashi
    公开号:US20070027147A1
    公开(公告)日:2007-02-01
    The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof: Formula (I) wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R 1 is a hydrogen atom, and so on; R 2 and R 3 are each a hydrogen atom, and so on; R 4 and R 5 are each a hydrogen atom, and so on; and the formula is a single bond or a double bond. According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.
  • ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF
    申请人:AbbVie Inc.
    公开号:US20200291024A1
    公开(公告)日:2020-09-17
    Disclosed herein are methods and compounds of augmenting and enhancing the production of type I IFNs in vivo. In some embodiments, the compounds disclosed herein are ENPP-1 inhibitors, pharmaceutical compositions, and methods for the treatment of cancer or a viral infection.
  • US7354946B2
    申请人:——
    公开号:US7354946B2
    公开(公告)日:2008-04-08
查看更多